300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oceania
LATAM
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
Czech Republic
China
Armenia
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Suzhou International Development Venture Capital, VC Fund

Suzhou International Development Venture Capital

VC Fund

Suzhou, China

Suzhou International Development Venture Capital is a venture capital and private equity firm.

Total investments:
99
Last investment:
Lead investor:
19%

Last updated:

Industries Suzhou International Development Venture Capital invests in

ManufacturingSemiconductorMedicalAdvanced MaterialsElectronics

Stages Suzhou International Development Venture Capital invests in

Funding RoundSeries ASeries BAngelSeed

Countries Suzhou International Development Venture Capital invests in

ChinaUnited States

Round sizes

Series A $1.6M–$15MSeries B $2.8M–$110M

Round size

Series A
$1.6M–$15M
Series B
$2.8M–$110M

Investment Focus

Industry

  • Manufacturing 35 (35%)
  • Semiconductor 16 (16%)
  • Medical 11 (11%)
  • Advanced Materials 9 (9%)
  • Electronics 8 (8%)
See all 84 industries →

Stage

  • Funding Round 24 (24%)
  • Series A 23 (23%)
  • Series B 13 (13%)
  • Angel 11 (11%)
  • Seed 10 (10%)
See all 11 stages →

Country

  • China 84 (85%)
  • United States 2 (2%)

Investments

CompanyDescriptionRoundLinks
Qingyan Technology Qingyan Technology
Qingyan Technology is an AI and data infrastructure firm specializing in world models and physical artificial intelligence. Series A / Aug 19, 2026
PMT Technologies PMT Technologies
PMT Technologies is a company that specializes in measurement technology with full independent research and development and production capabilities. $14.8M / Series B / Aug 05, 2026
Haimai Medical Haimai Medical
Haimai Medical is a platform for tissue engineering and regenerative medicine technology. It focused on the development and manufacture of allogeneic small-caliber tissue-engineered blood vessels suitable for the establishment of chronic renal failure dialysis vascular access, lower extremity arterial trauma blood vessel replacement, lowerextremity atherosclerosis, and coronary heart disease bypass surgery. Series A / Jun 12, 2026
Lyen Marine Lyen Marine
LYEN is committed to designing and producing reliable, high-performance propeller systems, including FPP, CPP, and Azimuth thrusters. $14.7M / Series B / May 22, 2026
Skylimit Entertainment Group Skylimit Entertainment Group
Sky Limit Entertainment Group is committed to creating the ultimate immersive social entertainment experience with VR. Series C / Mar 26, 2026
Zhifengqi
Zhifengqi is a high-tech company that focuses on the research and development of specialized semiconductor equipment. Seed / Jan 12, 2026
Yike Polymers Yike Polymers
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries. Series C / Jan 08, 2026
Audfly Technology Audfly Technology
Audfly Technologies is China's leading acoustic revolutionary technology firm. It is a global audio solutions leader and one of the main authorities on directed audio technology. Since early 2016, Audfly Technologies has been manufacturing and installing Audfly directional speakers for large corporations and industries all around the world. Venture - Series Unknown / Jan 04, 2026
Haimai Medical Haimai Medical
Haimai Medical is a platform for tissue engineering and regenerative medicine technology. It focused on the development and manufacture of allogeneic small-caliber tissue-engineered blood vessels suitable for the establishment of chronic renal failure dialysis vascular access, lower extremity arterial trauma blood vessel replacement, lowerextremity atherosclerosis, and coronary heart disease bypass surgery. $14.3M / Series A / Dec 29, 2025
Sanegene Bio
Sanegene Bio is currently operating in stealth mode. $110M / Series B / Dec 08, 2025
See all 99 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oceania
LATAM
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
Czech Republic
China
Armenia
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Suzhou International Development Venture Capital invest in?

Suzhou International Development Venture Capital invests primarily in Manufacturing, Semiconductor and Medical startups, most often at Funding Round and Series A stage. Most of the 99 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Suzhou International Development Venture Capital's check size?

Suzhou International Development Venture Capital typically joins rounds of $1.6M–$15M at Series A and $2.8M–$110M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Suzhou International Development Venture Capital participates in.

When did Suzhou International Development Venture Capital last invest?

The most recent investment recorded for Suzhou International Development Venture Capital closed in Aug 2026. Shizune tracks 99 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Suzhou International Development Venture Capital Suzhou International Development Venture Capital Find emails